Bactimicina Childrens Allergy Liquid
Product Images NDC 24286-1565

1 FDA label image from Dlc Laboratories, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Bactimicina Childrens Allergy (NDC 24286-1565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dlc Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bactimicina Children Allergy (Allergy 2025)

Bactimicina Children Allergy (Allergy 2025)
Label for BACTIMICINA CHILDRENS ALLERGY 12.5 mg/5mL oral liquid, an antihistamine containing diphenhydramine hydrochloride. The 4 FL OZ (118 mL) package features cherry flavor and includes a dosing cup. The label includes dosing directions, warnings, and drug facts in English and Spanish, stating relief for allergy symptoms such as sneezing, runny nose, itchy watery eyes, and itchy throat or nose. Manufactured by DLC Laboratories, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.